There is pressing need for third-party, tech-enabled training to enforcement agencies: BDCDA: Nandita Vijayasimha, Bengaluru ...

PCI once again opens portal for institutes to submit additional information for approval: Gireesh Babu, New Delhi Thursday, ...

US FDA grants fast track designation to Greenwich LifeSciences’ GLSI-100 in the HLA-A*02 patient population: Stafford, Texas Thursday, September 11, 2025, 16:00 Hrs [IST] Greenw ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that it has completed enrollment in the phase 3 SENTRY trial, which is evaluating ...

Our Bureau, Mumbai Thursday, September 11, 2025, 16:30 Hrs [IST] ...

IIT Kanpur researchers develop novel sensor to study how medicines activate vital receptors: Our Bureau, Mumbai Thursday, September 11, 2025, 16:15 Hrs [IST] Researchers at the In ...

Biocon, an innovation-led global biopharmaceutical company, announced the inauguration of its first US manufacturing facility in Cranbury, New Jersey, by its wholly owned subsidiary, Biocon Generics ...

Chinese NMPA approves Sanofi’s Tzield as first disease-modifying therapy for adult and paediatric patients with stage 2 type 1 diabetes: Paris Thursday, September 11, 2025, 09:0 ...

Sanofi to present new data from 14 abstracts across multiple sclerosis at ECTRIMS 2025 congress in Barcelona, Spain: Paris Thursday, September 11, 2025, 13:00 Hrs [IST] New data f ...

Galderma introduces Alastin in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market: Zug, Switzerland Thursday, September 11, 2025, 14:00 Hr ...

Stockholm, Sweden Thursday, September 11, 2025, 11:00 Hrs [IST] ...

Jharkhand DC issues guidelines on MRP revisions of medicines post-GST amendments: Peethaambaran Kunnathoor, Chennai Thursday, September 11, 2025, 08:00 Hrs [IST] In response to th ...